Skip to content
Bench Press
  • Home
  • About Us
  • Science Insights
Bench Press
Research news from Mass General Brigham
Facebook Twitter Linkedin Instagram
  • Home
  • About Us
  • Science Insights

Posts Tagged ‘ketamine’

Ketamine Approval Offers New Hope for Treatment-Resistant Depression, But Questions Remain

By Brian Burns | March 26, 2019
Sad woman

While the FDA’s approval of the first ketamine-based drug for treatment-resistant depression is encouraging, there are still a lot of details to work out, says Cristina Cusin, MD.

Read More

Research Shows Ketamine Could Be an Answer for Treatment-Resistant Depression

By MGH Research Institute | October 25, 2018

A Mass General research team is working to identify the ideal dosages for treating depression with ketamine.

Read More
Every medical breakthrough begins with a question. At Mass General Brigham, research gives scientists and clinicians the opportunity to explore those questions, make new discoveries and turn promising ideas into advances that can improve patient care and shape the future of medicine. Follow us to learn about the latest advances in research-infused care.
Facebook Twitter Linkedin Instagram